CONTACT US
contact us
logotype
CONTACT US

Have a Project in Mind? Say Hi!

  • Mon - Sun: 10am - 10pm
  • 27 Division St, New York,
    NY 10002, USA​

Newsroom

Press Releases

October 19, 2023
Business Wire

Qnovia Enters Collaboration with University of Virginia to Advance Inhaled Drug Candidates for Treating Infectious Diseases

April 4, 2023
Business Wire

Qnovia, Inc. Announces Former Director of FDA’s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor

November 8, 2022
Business Wire

Qnovia to Pursue UK Approval for Lead Asset QN-01 in Nicotine Replacement Therapy

September 28, 2022
Business Wire

Qnovia, Inc. Raises $17 Million in Series A Funding to Advance Its Inhalable Therapeutics Pipeline

September 13, 2022
Business Wire

Respira Technologies, Inc. Rebrands as “QNOVIA”; Adopts Qnovia, Inc. as Corporate Name

Media

December 16, 2022
Richmond Biz Journals

Qnovia aims to bring smoking cessation medical device to market in 2025

December 16, 2022
MediaPost

Qnovia Aiming For 2025 Approval Of Heatless Nicotine Nebulizer

December 16, 2022
Flipboard

Qnovia Aiming For 2025 Approval Of Heatless Nicotine Nebulizer

December 13, 2022
PharmaShots

Brian Quigley, CEO at Qnovia Shares Insights on Respira Technologies Rebranded as Qnovia

November 16, 2022
Pharmaphorum

Health Innovators – Brian Quigley and Mario Danek (Live from HLTH 2022)

November 2, 2022
Fortune

The role of board members during a market downturn

November 2, 2022
Yahoo! Finance

The role of board members during a market downturn

October 19, 2022
Coruzant Technologies

Brian Quigley

October 7, 2022
Drug Delivery Business

How Qnovia aims to use inhaled therapeutics for smoking cessation

October 19, 2023

Qnovia Enters Collaboration with University of Virginia to Advance Inhaled Drug Candidates for Treating Infectious Diseases

READ MORE
April 4, 2023

Former FDA tobacco head: Smokers need a new tool to quit

READ MORE
April 4, 2023

Qnovia, Inc. Announces Former Director of FDA’s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor

READ MORE
March 31, 2023

Ex-FDA Tobacco Head Advising Company on Smoker Cessation

READ MORE
February 24, 2023

Qnovia Raises $17 million for Nebulizer

READ MORE
January 8, 2023

It’s Pharma Time: Why Merck and Lilly Are Buys, but Not Pfizer.

READ MORE
December 27, 2022

Brian Quigley, CEO at Qnovia Shares his Views on Raising Series A Funding

READ MORE
December 19, 2022

2023 forecast: The biopharma name changing craze and the shifting sands of corporate branding

READ MORE
December 16, 2022

Qnovia aims to bring smoking cessation medical device to market in 2025

READ MORE
#side-panel.side-panel {width: 500px;}#side-panel.side-panel .side-panel_sidebar {padding: 70px 0px 50px 60px;background-color: #FFFFFF;} Qnovia